Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongxie Anchang Formula
- Development stage
- Unknown
- Lead developer
- Beijing University of Chinese Medicine East Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tongxie Anchang Formula (TXACD) is a traditional Chinese medicine (TCM) herbal prescription developed by Professor Li Junxiang at Dongfang Hospital, Beijing University of Chinese Medicine. It is a multi-herb botanical drug composed of seven ingredients: Atractylodes macrocephala, Paeoniae Radix Alba, Coptidis Rhizoma, Rhizoma Zingiberis Preparata, Citrus reticulata, Cicadae Periostracum, and Mume Fructus. Indicated for diarrhea-predominant irritable bowel syndrome (IBS-D), particularly in patients with liver depression and spleen deficiency, the formula acts by regulating the NGF/TrkA signaling pathway to alleviate visceral hypersensitivity. It is currently being evaluated in Phase 2 clinical trials in China as a granule formulation.
- Other names
- Tongxie Anchang DecoctionTXACD通泻安肠方通泻安肠汤
02
Targets
NGF/TrkA (Nerve growth factor/Tropomyosin receptor kinase A signaling axis)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on Tongxie Anchang Formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongxie Anchang Formula.